How big is the CRISPR Technology Market?

The CRISPR Technology Market size is expected to reach USD 3.78 billion in 2024 and grow at a CAGR of 19.89% to reach USD 9.34 billion by 2029. Read More

What is the current CRISPR Technology Market size?

In 2024, the CRISPR Technology Market size is expected to reach USD 3.78 billion. Read More

Who are the key players in CRISPR Technology Market?

Merck KGaA, GenScript, Danaher Corporation (Integrated DNA Technologies (IDT)), PerkinElmer Inc. (Horizon Discovery Group) and ThermoFisher Scientific, Inc. are the major companies operating in the CRISPR Technology Market. Read More

Which is the fastest growing region in CRISPR Technology Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in CRISPR Technology Market?

In 2024, the North America accounts for the largest market share in CRISPR Technology Market. Read More

What years does this CRISPR Technology Market cover, and what was the market size in 2023?

In 2023, the CRISPR Technology Market size was estimated at USD 3.03 billion. The report covers the CRISPR Technology Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the CRISPR Technology Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

CRISPR Technology Market Share

Statistics for the 2023 & 2024 CRISPR Technology market share, created by Mordor Intelligence™ Industry Reports. CRISPR Technology share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of CRISPR Technology Industry

The CRISPR technology market is moderately fragmented and competitive, with several major players. The rising focus of companies on personalized medicine, co-development activities, and increased cases of adverse drug reactions are expected to boost the competitive nature of the market studied. Companies like ThermoFisher Scientific Inc., Merck KGaA, GenScript, Danaher Corporation (Integrated DNA Technologies (IDT)), and PerkinElmer Inc. hold a substantial share in the market.